Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - SUPERNUS PHARMACEUTICALS, INC. | a2231272zex-32_2.htm |
| EX-32.1 - EX-32.1 - SUPERNUS PHARMACEUTICALS, INC. | a2231272zex-32_1.htm |
| EX-31.2 - EX-31.2 - SUPERNUS PHARMACEUTICALS, INC. | a2231272zex-31_2.htm |
| EX-31.1 - EX-31.1 - SUPERNUS PHARMACEUTICALS, INC. | a2231272zex-31_1.htm |
| EX-23.2 - EX-23.2 - SUPERNUS PHARMACEUTICALS, INC. | a2231272zex-23_2.htm |
| 10-K - 10-K - SUPERNUS PHARMACEUTICALS, INC. | a2231272z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements:
1) Registration Statement (Form S-8 No. 333-181479) pertaining to the 2005 Stock Plan, the 2012 Equity Incentive Plan, and the 2012 Employee Stock Purchase Plan of Supernus Pharmaceuticals, Inc.
2) Registration Statement (Form S-3 No. 333-200716) of Supernus Pharmaceuticals, Inc.
3) Registration Statement (Form S-8 No. 333-201049) pertaining to the Amended and Restated 2012 Equity Incentive Plan and the Amended and Restated 2012 Employee Stock Purchase Plan of Supernus Pharmaceuticals, Inc.
4) Registration Statement (Form S-8 No. 333-216135) pertaining to the Second Amended and Restated 2012 Equity Incentive Plan and the Second Amended and Restated 2012 Employee Stock Purchase Plan of Supernus Pharmaceuticals, Inc.
of our report dated March 12, 2015, except for Note 2, as to which the date is January 20, 2017, with respect to the consolidated financial statements of Supernus Pharmaceuticals, Inc., as of and for the year ended December 31, 2014, included in this Annual Report (Form 10-K) for the year ended December 31, 2016.
| /s/ Ernst & Young | ||
McLean, VA March 13, 2017 |
1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM